⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IBIO News
iBio, Inc. Common Stock
Immorta Bio Announces Publication of International Patent Application for SenoVax™, a First-in-Class Senolytic Immunotherapy
prnewswire.com
IBIO
iBio to Participate in the 8th Annual Evercore Healthcare Conference
globenewswire.com
IBIO
iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update
globenewswire.com
IBIO
iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance
globenewswire.com
IBIO